MSB 3.81% $1.14 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-862

  1. 614 Posts.
    lightbulb Created with Sketch. 311
    Yes but my point is the class action is based on issues with misleading efficacy and non disclosure of trial deficiencies, which is in a different ballpark than SI saying "we should know in a few weeks". Last time he said a few weeks for the back pain readout it took 6 months yet no mention of that in class action?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.14
Change
-0.045(3.81%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.18 $1.18 $1.13 $3.143M 2.746M

Buyers (Bids)

No. Vol. Price($)
3 47040 $1.14
 

Sellers (Offers)

Price($) Vol. No.
$1.14 33368 14
View Market Depth
Last trade - 12.58pm 17/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.